CX3CR1 and Alzheimer disease: Further support of this is demonstrated in the α-synuclein-induced inflammation model of Alzheimer’s disease, where the use of CX3CR1 knockout mice has been demonstrated to reduce inflammation during this disease state compared to wild-type mice [13].